No amendment in the last 12 months on an offering that may still be open — Summit Biolabs, Inc. (latest filing Aug 20, 2020)
The latest filing for this offering is dated Aug 20, 2020 (first sale Aug 19, 2020). It reports $235,000 sold of $12,000,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
Sources
- Form D · Aug 20, 2020 ↗ (Aug 20, 2020)
- Summit Biolabs, Inc. — PartnerFacts page ↗ (Aug 20, 2020)